Month: February 2021

SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company focused on creating and delivering engineered cells as medicines, today announced the pricing of its upsized initial public offering of 23,500,000 shares of its common stock at a public offering price of $25.00 per share. All of the shares of common stock are being offered by Sana. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sana, are expected to be $587.5 million. Sana’s common stock is expected to begin trading on The Nasdaq Global Select Market on February 4, 2021, under the ticker symbol “SANA.” The offering is expected to close on February 8, 2021, subject to the satisfaction of customary closing conditions. In addition, Sana has granted...

ALHAMBRA, CA, Feb. 03, 2021 (GLOBE NEWSWIRE) — In a release issued under the same headline on Wednesday, February 3rd by EMCORE Corporation (Nasdaq: EMKR), please note that the word “revenue” was missing following “combining” in the 3rd paragraph. The corrected release follows:EMCORE Corporation (Nasdaq: EMKR), a leading provider of advanced mixed-signal products that serve the aerospace & defense and broadband communications markets, today announced results for the fiscal 2021 first quarter ended December 31, 2020 (1Q21). Management will host a conference call to discuss financial and business results tomorrow, Thursday, February 4, 2021, at 8:00 AM Eastern Time.Consolidated revenue for 1Q21 was $33.4 million, comprised of $13.6 million from the Aerospace & Defense segment and $19.8 million from the Broadband segment....

BRENTWOOD, Tenn., Feb. 03, 2021 (GLOBE NEWSWIRE) — American Addiction Centers (AAC), a leading provider of substance use services, is going live on Facebook with its new show – “Addiction Talk.” The show interviews celebrities, influencers and everyday people who’ve been impacted by addiction and/or mental health. The show’s goal is to raise awareness about addiction while reducing the stigma often associated with the disease.To watch the first episode and to learn more about the lineup of guests, visit www.americanaddictioncenters.org/social/addiction-talk.“There is nothing more powerful than hearing someone else’s journey and realizing that you are not alone in this fight,” said Stephen Ebbett, AAC’s chief digital and marketing officer. “The idea for the talk show was sparked after a Facebook Live interview we did last year...

New York, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) — Atlas Crest Investment Corp. II (NYSE: ACII.U, the “Company”) announced today that it priced its upsized initial public offering of 30,000,000 units at a price to the public of $10.00 per unit. The units are expected to commence trading on February 4, 2021 on The New York Stock Exchange (the “NYSE”) under the ticker symbol “ACII.U”. Each unit consists of one share of Class A common stock and one-fourth of one warrant, each whole warrant entitling the holder to purchase one share of Class A common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be traded on the NYSE under the symbols “ACII” and “ACII.WS,” respectively....

Charlotte, NC, Feb. 03, 2021 (GLOBE NEWSWIRE) — Ballantyne Strong, Inc. (NYSE American: BTN) (“Ballantyne Strong” or the “Company”) today announced the pricing of its underwritten public offering of 3,290,000 shares of its common stock at a public offering price of $2.30 per share, for gross proceeds of $7,567,000, before deducting underwriting discounts, commissions and offering expenses. All of the shares of common stock are being offered by the Company.The offering is expected to close on February 8, 2021, subject to satisfaction of customary closing conditions.ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering.The securities will be offered and sold pursuant to a shelf registration statement on Form S-3 (File No. 333-238757), including a base prospectus, filed...

GAITHERSBURG, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that the company has executed a binding Heads of Terms agreement with the government of Switzerland to supply six million doses of its protein-based COVID-19 vaccine candidate, NVX-CoV2373, to the country.“The government of Switzerland is working proactively to ensure a sufficient supply of our vaccine that could protect its citizens from COVID-19,” said John J. Trizzino, Chief Commercial Officer and Chief Business Officer of Novavax. “Addressing this global public health crisis requires collaboration, and we appreciate their partnership to provide an urgently needed vaccine to stem the pandemic.”Novavax and Switzerland will negotiate a final...

VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) — Gen III Oil Corporation (“Gen III” or the “Company”) (TSX-V: GIII) (OTCQX: ISRJF) is pleased to announce that, further to its news release of November 24, 2020, it has settled $200,250 in debt (“Debt”) owing to certain directors of the Company, in exchange for 513,460 common shares (the “Shares”) at a deemed price of $0.39 per Share (the “Shares for Debt Transactions”).The Shares for Debt Transactions are each a “related party transaction” under applicable securities laws, and each director of the Company abstained from voting on the resolution approving the Shares for Debt Transaction that related to them. Each Shares for Debt Transaction is exempt from the formal valuation and minority approval requirements under Multilateral Instrument 61-101, as neither...

BOSTON and ROCKVILLE, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next generation therapeutics for cancer, today announced the pricing of its upsized initial public offering of 7,000,052 shares of common stock at a public offering price of $19.00 per share. The gross proceeds to Sensei from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Sensei, are expected to be approximately $133.0 million. All of the shares are being offered by Sensei and are expected to begin trading on The Nasdaq Global Market on February 4, 2021 under the ticker symbol “SNSE.” In addition, Sensei has granted the underwriters a 30-day option to purchase up to an additional 1,050,007 shares of...

BLACKSBURG, Va., Feb. 03, 2021 (GLOBE NEWSWIRE) — Landos Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutics for patients with autoimmune diseases, today announced the pricing of its initial public offering of 6,250,000 shares of common stock at the public offering price of $16.00 per share, for total gross proceeds of $100 million, before deducting underwriting discounts and commissions and offering expenses payable by Landos Biopharma. All of the shares of the common stock are being offered by Landos Biopharma.The shares are expected to begin trading on the Nasdaq Global Select Market on February 4, 2021 under the trading symbol of “LABP.” The offering is expected to close on February 8, 2021, subject to customary closing conditions. In addition, Landos Biopharma has granted...

BERLIN, Feb. 03, 2021 (GLOBE NEWSWIRE) — Atotech Limited (“Atotech”), a leading specialty chemicals technology company and a market leader in advanced electroplating solutions, has priced its initial public offering of 29,268,000 of its common shares at $17.00 per share. The shares are expected to begin trading on Thursday, February 4, 2021 on the New York Stock Exchange under the ticker symbol “ATC,” and the offering is expected to close on February 8, 2021, subject to customary closing conditions. The underwriters of the offering will also have a 30-day option to purchase up to an additional 4,390,200 common shares from certain affiliates of The Carlyle Group Inc. (the “selling shareholders”).Citigroup, Credit Suisse, BofA Securities and J.P. Morgan are lead book-running managers for the proposed initial public offering. Additional...